Lyell Immunopharma Reports $38.8M Loss in Q3
Markets & Money Today | 2 Min News | The Daily News Now! - Podcast autorstwa The Daily News Now! - Piątki
Kategorie:
Lyell Immunopharma reports significant third-quarter loss, with a net loss of $38.8 million and a loss of $2.13 per share. Revenue stands at a modest $15,000. The companys performance will be closely monitored as they navigate the biotechnology sector.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
